Appen Limited

ASX:APX Stok Raporu

Piyasa değeri: AU$318.9m

Appen Gelecekteki Büyüme

Future kriter kontrolleri 4/6

Appen kazanç ve gelirin sırasıyla yıllık 73% ve 14.1% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 75.4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde -3.7% olacağı tahmin edilmektedir.

Anahtar bilgiler

73.0%

Kazanç büyüme oranı

75.40%

EPS büyüme oranı

IT kazanç büyümesi-4.7%
Gelir büyüme oranı14.1%
Gelecekteki özkaynak getirisi-3.69%
Analist kapsamı

Low

Son güncelleme30 Apr 2026

Gelecekteki son büyüme güncellemeleri

Recent updates

Analiz Güncellemesi Apr 24

APX: 2026 Earnings Outlook Will Expose Risk In Elevated P/E

Analysts have updated their Appen fair value estimate from A$0.52 to A$0.59. This reflects adjusted assumptions for revenue growth, profit margin and future P/E, along with the application of a revised discount rate.
Analiz Güncellemesi Apr 10

APX: Upgraded Outlook Will Rely On 2026 Earnings Guidance Delivery

Analysts have lifted Appen's implied fair value target from A$1.27 to A$1.79, reflecting updated views on revenue growth, profit margins, and a lower future P/E multiple in their models. What's in the News Appen issued group earnings guidance for fiscal 2026, giving investors clearer visibility on expected performance (Key Developments).
Analiz Güncellemesi Mar 27

APX: Fiscal 2026 Guidance And Margin Outlook Will Support Long Term Upside

Analysts have lifted their price target for Appen to A$2.35, reflecting updated assumptions around slightly higher revenue growth, a modestly better profit margin and a lower future P/E multiple, offset by a marginally reduced discount rate. What's in the News Appen released group earnings guidance for fiscal 2026, giving investors a clearer view of management expectations for the medium term (company guidance).
Analiz Güncellemesi Mar 12

APX: Fiscal 2026 Earnings Guidance Will Support Long Term Upside

Analysts have maintained their A$2.35 price target on Appen, with small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E contributing to a broadly unchanged view of fair value. What's in the News Appen issued group earnings guidance for fiscal 2026, with expected revenue in a range of $270 million to $300 million, giving investors a reference point for sizing the business over the next couple of years (Key Developments).
Analiz Güncellemesi Feb 26

APX: Higher Profit Margin Outlook Will Support Long Term Upside

Analysts have lifted their price target on Appen from A$1.85 to A$2.35, citing revised assumptions around revenue growth, profit margins, and a lower future P/E multiple in their models. What's in the News Appen issued group earnings guidance for fiscal 2026, with expected revenue in the range of $270 million to $300 million (Company guidance, Key Developments).
Analiz Güncellemesi Feb 12

APX: Higher Future P/E Assumptions Will Support Long Term Upside

Analysts have maintained their A$1.85 price target for Appen. A shift in their assumptions toward a higher discount rate, lower revenue growth and profit margins, and a much higher future P/E multiple explains why the target itself has not changed.
Analiz Güncellemesi Jan 29

APX: Higher Margin Outlook Will Support Improved Long Term P/E Multiple

Analysts have lifted their price target on Appen from A$1.65 to A$1.85, citing updated assumptions for revenue growth, profit margins and a lower future P/E multiple as key drivers of the change. Valuation Changes Fair Value: Updated from A$1.65 to A$1.85, indicating a higher assessed value per share in the latest model.
Analiz Makalesi Jan 08

There's Reason For Concern Over Appen Limited's (ASX:APX) Massive 30% Price Jump

Appen Limited ( ASX:APX ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...
Analiz Güncellemesi Aug 29

LLM And Generative AI Projects Will Secure A Bright Future

Despite a notable improvement in Appen’s net profit margin and a sharp decline in its future P/E ratio, analysts have significantly lowered their fair value estimate, with the consensus price target dropping from A$1.48 to A$1.27. Valuation Changes Summary of Valuation Changes for Appen The Consensus Analyst Price Target has significantly fallen from A$1.48 to A$1.27.
Analiz Makalesi Aug 20

Appen Limited (ASX:APX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

ASX:APX 1 Year Share Price vs Fair Value Explore Appen's Fair Values from the Community and select yours Appen Limited...
Analiz Makalesi Jun 11

Companies Like Appen (ASX:APX) Can Afford To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analiz Makalesi May 14

Appen Limited (ASX:APX) Shares Fly 34% But Investors Aren't Buying For Growth

Those holding Appen Limited ( ASX:APX ) shares would be relieved that the share price has rebounded 34% in the last...
User avatar
Yeni Analiz Apr 22

LLM And Generative AI Projects Will Secure A Bright Future

Strong growth in generative AI projects and strategic positioning in key markets imply significant revenue expansion and diversified income sources.
Analiz Makalesi Mar 21

Appen Limited (ASX:APX) Looks Inexpensive After Falling 61% But Perhaps Not Attractive Enough

Appen Limited ( ASX:APX ) shareholders won't be pleased to see that the share price has had a very rough month...
Analiz Makalesi Jan 04

Appen Limited's (ASX:APX) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Despite an already strong run, Appen Limited ( ASX:APX ) shares have been powering on, with a gain of 26% in the last...
Analiz Makalesi Oct 15

Appen Limited (ASX:APX) Stock Rockets 44% As Investors Are Less Pessimistic Than Expected

Appen Limited ( ASX:APX ) shares have continued their recent momentum with a 44% gain in the last month alone. The...
Analiz Makalesi Aug 31

Appen Limited's (ASX:APX) Shares Bounce 28% But Its Business Still Trails The Industry

Appen Limited ( ASX:APX ) shares have continued their recent momentum with a 28% gain in the last month alone. Not all...
Analiz Makalesi Jul 30

Appen (ASX:APX) Will Have To Spend Its Cash Wisely

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analiz Makalesi Jun 04

Appen Limited's (ASX:APX) Price Is Right But Growth Is Lacking

Appen Limited's ( ASX:APX ) price-to-sales (or "P/S") ratio of 0.3x might make it look like a buy right now compared to...
Analiz Makalesi Apr 04

We're A Little Worried About Appen's (ASX:APX) Cash Burn Rate

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analiz Makalesi Feb 29

There's No Escaping Appen Limited's (ASX:APX) Muted Revenues Despite A 66% Share Price Rise

Those holding Appen Limited ( ASX:APX ) shares would be relieved that the share price has rebounded 66% in the last...
Analiz Makalesi Jan 15

The Market Doesn't Like What It Sees From Appen Limited's (ASX:APX) Revenues Yet As Shares Tumble 27%

To the annoyance of some shareholders, Appen Limited ( ASX:APX ) shares are down a considerable 27% in the last month...
Analiz Makalesi Aug 24

When Should You Buy Appen Limited (ASX:APX)?

Appen Limited ( ASX:APX ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in...
Analiz Makalesi May 15

Downgrade: Here's How Analysts See Appen Limited (ASX:APX) Performing In The Near Term

Today is shaping up negative for Appen Limited ( ASX:APX ) shareholders, with the analysts delivering a substantial...
Analiz Makalesi May 10

Why Appen Limited (ASX:APX) Could Be Worth Watching

While Appen Limited ( ASX:APX ) might not be the most widely known stock at the moment, it received a lot of attention...
Analiz Makalesi Apr 13

Are Investors Undervaluing Appen Limited (ASX:APX) By 21%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Appen fair value estimate is AU$3.54 Appen's AU$2.80 share...

Kazanç ve Gelir Büyüme Tahminleri

ASX:APX - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20283642430424
12/31/20273291920334
12/31/202628012224
12/31/2025233-22623N/A
9/30/2025229-22-312N/A
6/30/2025225-22-131N/A
3/31/2025230-21-130N/A
12/31/2024235-20-14-1N/A
9/30/2024242-56-25-11N/A
6/30/2024248-93-36-21N/A
3/31/2024261-105-39-22N/A
12/31/2023274-118-43-23N/A
9/30/2023309-196-30-6N/A
6/30/2023345-273-1711N/A
3/31/2023367-256-1315N/A
12/31/2022388-239-1018N/A
9/30/2022411-113632N/A
6/30/2022434122245N/A
3/31/2022440202749N/A
12/31/2021447293154N/A
9/30/2021428282449N/A
6/30/2021409271844N/A
3/31/2021411323154N/A
12/31/2020413364465N/A
9/30/2020411345169N/A
6/30/2020401315771N/A
3/31/2020354274355N/A
12/31/2019376293647N/A
9/30/201933530N/A44N/A
6/30/201932033N/A45N/A
3/31/201929131N/A39N/A
12/31/201825729N/A33N/A
9/30/201822022N/A24N/A
6/30/201818215N/A14N/A
3/31/201815813N/A12N/A
12/31/201713011N/A10N/A
9/30/201711711N/A12N/A
6/30/201710110N/A14N/A
3/31/2017939N/A12N/A
12/31/2016808N/A9N/A
9/30/2016818N/A9N/A
6/30/2016758N/A9N/A
3/31/2016707N/A6N/A
12/31/2015606N/A3N/A
9/30/2015504N/A3N/A
6/30/2015462N/A3N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: APX önümüzdeki 3 yıl içerisinde kârlı hale gelmesi öngörülüyor; bu da tasarruf oranından ( 3.6% ) daha hızlı bir büyüme olarak değerlendiriliyor.

Kazançlar ve Piyasa: APX önümüzdeki 3 yıl içerisinde karlı hale gelmesi öngörülüyor ki bu da ortalama piyasa büyümesinin üzerinde kabul ediliyor.

Yüksek Büyüme Kazançları: APX önümüzdeki 3 yıl içinde karlı hale gelmesi bekleniyor.

Gelir ve Pazar: APX şirketinin gelirinin (yıllık 14.1% ) Australian pazarından (yıllık 6.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: APX şirketinin gelirinin (yıllık 14.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: APX 3 yıl içinde kârsız olması bekleniyor.


Büyüyen şirketleri keşfedin

Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/07 16:33
Gün Sonu Hisse Fiyatı2026/05/07 00:00
Kazançlar2025/12/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Appen Limited 9 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Josh KannourakisBarrenjoey Markets Pty Limited
Conor O’PreyCanaccord Genuity
Siraj AhmedCitigroup Inc